Currently holds positions in Nektar Therapeutics and Twist Bioscience Corp
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Nektar Therapeutics | Jan. 8, 2007 - |
Lead Independent Director | Twist Bioscience Corp | Oct. 30, 2018 - |
Director | Twist Bioscience Corp | Jan. 1, 2014 - Oct. 30, 2018 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-02-09 | 2024-02-08 |
Twist Bioscience Corp
(TWST)
|
S Sale |
4,110
-6.0%
34.98143,784 USD |
4,110 -6.0% | 34.98 | 143,784 USD | |
2023-09-20 | 2022-09-22 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
10,200
-3.6%
0.676,834 USD |
10,200 -3.6% | 0.67 | 6,834 USD | |
2022-09-26 | 2022-09-22 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
5,100
-2.2%
3.1916,269 USD |
5,100 -2.2% | 3.19 | 16,269 USD | |
2022-02-08 | 2022-02-04 |
Twist Bioscience Corp
(TWST)
|
S Sale |
253
-0.5%
58.8814,896 USD |
253 -0.5% | 58.88 | 14,896 USD | |
2021-11-03 | 2021-11-01 |
Twist Bioscience Corp
(TWST)
|
PS Planned sale |
4,000
-7.3%
120.15480,614 USD |
4,000 -7.3% | 120.15 | 480,614 USD | |
2021-10-25 | 2021-10-21 |
Twist Bioscience Corp
(TWST)
|
PS Planned sale |
3,700
-6.3%
120.15444,540 USD |
3,700 -6.3% | 120.15 | 444,540 USD | |
2021-10-21 | 2021-10-19 |
Twist Bioscience Corp
(TWST)
|
PS Planned sale |
300
-0.5%
120.0036,000 USD |
300 -0.5% | 120.00 | 36,000 USD | |
2021-09-14 | 2021-09-10 |
Twist Bioscience Corp
(TWST)
|
PS Planned sale |
4,000
-6.3%
120.23480,908 USD |
4,000 -6.3% | 120.23 | 480,908 USD | |
2021-06-25 | 2021-06-23 |
Twist Bioscience Corp
(TWST)
|
PS Planned sale |
4,000
-5.6%
120.10480,409 USD |
4,000 -5.6% | 120.10 | 480,409 USD | |
2021-04-16 | 2021-04-14 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
8,000
-2.8%
18.98151,840 USD |
8,000 -2.8% | 18.98 | 151,840 USD | |
2021-02-09 | 2021-02-05 |
Twist Bioscience Corp
(TWST)
|
PS Planned sale |
706
-1.0%
159.54112,635 USD |
706 -1.0% | 159.54 | 112,635 USD | |
2020-09-25 | 2020-09-25 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
5,500
-1.9%
17.7597,625 USD |
5,500 -1.9% | 17.75 | 97,625 USD | |
2020-09-10 | 2020-09-08 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
8,000
-2.8%
18.53148,240 USD |
8,000 -2.8% | 18.53 | 148,240 USD | |
2020-07-10 | 2020-07-08 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
8,000
-2.8%
24.58196,640 USD |
8,000 -2.8% | 24.58 | 196,640 USD | |
2020-04-17 | 2020-04-15 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
197
-0.1%
19.023,747 USD |
197 -0.1% | 19.02 | 3,747 USD | |
2020-04-17 | 2020-04-15 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
7,803
-2.7%
18.36143,263 USD |
7,803 -2.7% | 18.36 | 143,263 USD | |
2020-03-13 | 2020-03-11 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
1,200
-0.4%
17.4120,892 USD |
1,200 -0.4% | 17.41 | 20,892 USD | |
2020-03-13 | 2020-03-11 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
6,800
-2.4%
16.68113,424 USD |
6,800 -2.4% | 16.68 | 113,424 USD | |
2020-02-14 | 2020-02-12 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
3,599
-1.3%
23.7285,368 USD |
3,599 -1.3% | 23.72 | 85,368 USD | |
2020-02-14 | 2020-02-12 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
4,401
-1.5%
23.32102,631 USD |
4,401 -1.5% | 23.32 | 102,631 USD | |
2019-10-01 | 2019-09-27 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
4,000
-1.4%
17.9971,960 USD |
4,000 -1.4% | 17.99 | 71,960 USD | |
2016-09-19 | 2016-09-15 |
Nektar Therapeutics
(NKTR)
|
PS Planned sale |
12,000
-4.6%
19.21230,520 USD |
12,000 -4.6% | 19.21 | 230,520 USD |